Nocturnal enuresis is a common symptom in children with sickle cell disease (SCD). Risk factors for development of enuresis are currently unknown. An early manifestation of SCD-associated kidney damage is glomerular hyperfiltration. We test the hypothesis that in a pediatric SCD cohort, individuals with hyperfiltration are more likely to have nocturnal enuresis when compared to children without hyperfiltration. To assess the relationship between nocturnal enuresis and hyperfiltration, we retrospectively evaluated children with SCD enrolled in the Evaluation of Nocturnal Enuresis and Barriers to Treatment among Pediatric Patients with SCD study and prospectively identified children who reported nocturnal enuresis and were enrolled in the longitudinal cohort study Sickle Cell Clinical Research and Intervention Program. Nocturnal enuresis occurred in 46.5% of Pediatric Patients with Sickle Cell Disease participants and was more frequent in participants with HbSS/HbSβ 0 thalassemia and in male participants. We did not identify an association between hyperfiltration from 3 to 5 years of age with the later development of enuresis. Severe SCD genotypes and male sex were associated with nocturnal enuresis after age 5 years. We could not identify additional renal or hematologic predictors associated with the diagnosis of nocturnal enuresis. Future studies should incorporate nonrenal risk factors into studies that predict development of enuresis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385885PMC
http://dx.doi.org/10.1097/MPH.0000000000002426DOI Listing

Publication Analysis

Top Keywords

nocturnal enuresis
32
sickle cell
16
enuresis
12
cell disease
12
development enuresis
12
enuresis hyperfiltration
8
children sickle
8
nocturnal
8
risk factors
8
pediatric patients
8

Similar Publications

The sleep disorder nocturnal enuresis (NE) affects children's health and quality of life, as well as places a heavy burden on their families. Treatment improves the child's quality of life. Unfortunately, some parents do not seek treatment for their children because they are unaware or misinformed about NE.

View Article and Find Full Text PDF

Patients with overactive bladder syndrome-wet (OAB-wet) experience urgency urinary incontinence, particularly urinary frequency and nocturia. Nocturnal enuresis (NE) is less addressed among OAB-wet patients. The study evaluated the prevalence of NE, lower urinary tract symptoms (LUTS), urodynamic factors, and social factors in OAB-wet patient.

View Article and Find Full Text PDF

Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism.

Psychopharmacol Bull

January 2025

Alamiri, MD, ABPN, ScD, Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Shuwaikh, State of Kuwait.

Herein, authors report on an ASD child with comorbid ADHD, ID, metabolic syndrome and nocturnal enuresis that failed multiple trials of psychotropic agents for behavioural dyscontrol. Viloxazine adjuventia brought about remarkable improvement spanning different domains. Purported pharmacodynamic mechanisms are briefly discussed.

View Article and Find Full Text PDF

Background: Nocturnal enuresis (NE), commonly referred to as nighttime bed wetting, is a common condition characterized by involuntary urination during sleep. This condition affects a significant number of children worldwide with a higher prevalence in boys than girls aged 6-12 years old. This study aims to evaluate the symptoms, assess the risk factors and address the response to different management types of this disorder among children and adolescents living in the Qassim region, Saudi Arabia.

View Article and Find Full Text PDF

The impact of constipation on lower urinary tract function and treatment response in patients with non-monosymptomatic enuresis.

BMC Urol

December 2024

Division of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, 16F, #289, Chienkuo Road, Xindian, New Taipei, 23142, Taiwan.

Purpose: The purpose of this study was to compare the differences in lower urinary tract function and treatment response between non-monosymptomatic nocturnal enuresis (NMNE) pediatric patients with and without constipation.

Method: We retrospectively analyzed pediatric patients diagnosed as NMNE from our enuresis database. Inclusion criteria were children aged 5 years or older with a follow-up duration of at least one month.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!